Seroepidemiology of Hepatitis B Virus Infection in İstanbul: A 20-year Survey
Journal Title: Viral Hepatitis Journal - Year 2016, Vol 22, Issue 3
Abstract
Objective: Turkey is an intermediate endemic country for hepatitis B virus (HBV) infection, with the prevalence rates showing regional differences. The aim of this study was to determine the recent prevalence of HBV infection among adults in İstanbul and to evaluate the impact of national vaccination program that started in 1998. Materials and Methods: Data of three healthcare centers from 3 different districts in İstanbul between 1995 and 2015 were obtained. HBV status of the participants was evaluated according to their hepatitis B surface antigen (HBsAg) and anti-HBs results. The change in HBV prevalence was evaluated by dividing the time included in the study into three periods: 1995-2002, 2003-2009 and 2010-2015. Statistical comparison between groups studied in each period was performed. To evaluate the impact of vaccination, the patients of 15-17 years of age were compared with the rest of the last study group. Results: Totally, 26001 adult patients were included in the study. HBsAg and anti-HBs tested positive in 4.24% and 16.81% of patients, respectively. When the 20 years included in the study were divided into three periods and each studied separately, the positive results for HBsAg decreased from 5.34% to 4.8% and 3.08%, and positive anti-HBs results increased from 14.24% to 15.45% and 19.57%, the difference between the groups being statistically significant (p<0.001). In vaccinated group (n=287), no one tested positive for HBsAg and 30.3% of patients tested positive for anti-HBs, being statistically different from the rest of the group (p<0.001). Conclusion: Despite the positive effects of vaccination, chronic HB remains a serious health problem.
Authors and Affiliations
Yavuz FURUNCUOĞLU, Filiz SAĞLAM, Filiz Füsun BÖLÜKBAŞ, Cengiz BÖLÜKBAŞ, Recep ÖZTÜRK
Keywords
Related Articles
- EP ID EP228495
- DOI 10.4274/vhd.30932
- Views 53
- Downloads 0
Elbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Report
Hepatitis C is a viral disease having a worldwide importance and posing a risk for liver complications. With the new treatment options, it is easy to manage with higher rates of success. Among them, one of the most recen...
Failure of Direct-Acting Antiviral Agents Due to Incomplete Hepatitis C Virus Genotyping
Current direct-acting antivirals (DAAs) have high success rates in the treatment of chronic hepatitis C virus (HCV) infection. However, 1-15% of patients fail to achieve viral eradication. Some factors may play a role in...
Distribution of Hepatitis C Virus Genotypes in Aydın Province
Objectives: In this study, we evaulated the distribution and alteration of hepatitis C virus (HCV) genotypes throughout years which has a clinical importance in the treatment and follow-up. Materials and Methods: Test re...
Determination of Resistance Mutation in Chronic Hepatitis B Patients Using Antiviral Drugs at Our Hospital
Objective: In this study, it is aimed to determine the mutations responsible for drug resistance in patients with chronic hepatitis B virus (HBV) infection received/receiving antiviral treatment at our hospital and to ex...
Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals
Objective: Chronic hepatitis C (CHC) virus infection is one of the leading causes of chronic liver disease in all over the world. The prevalence of CHC is almost 0.5-1% in Turkey. Until recently, pegylated-interferon (PE...